These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8610636

  • 1. 5-Fluorouracil and alpha-interferon in hepatocellular carcinoma.
    Stuart K, Tessitore J, Huberman M.
    Am J Clin Oncol; 1996 Apr; 19(2):136-9. PubMed ID: 8610636
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.
    Uchino K, Obi S, Tateishi R, Sato S, Kanda M, Sato T, Arano T, Enooku K, Goto E, Masuzaki R, Nakagawa H, Asaoka Y, Kondo Y, Yamashiki N, Goto T, Shiina S, Omata M, Yoshida H, Koike K.
    J Gastroenterol; 2012 Oct; 47(10):1152-9. PubMed ID: 22438097
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma.
    Joffe JK, Perren TJ, Bradley C, Primrose J, Hallam S, Ward U, Illingworth JM, Selby PJ.
    Br J Cancer; 1997 Oct; 75(3):423-6. PubMed ID: 9020490
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP.
    Cancer; 1995 May 01; 75(9):2197-202. PubMed ID: 7712428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A report of infusional 5-fluorouracil and subcutaneous alpha-2A-interferon in the treatment of advanced colorectal carcinoma.
    Koo WH, Ang PT.
    Ann Acad Med Singap; 1996 Mar 01; 25(2):210-4. PubMed ID: 8799007
    [Abstract] [Full Text] [Related]

  • 12. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Chi KH, Chan WK, Shu CH, Law CK, Chen SY, Yen SH, Chen KY.
    Cancer; 1995 Dec 01; 76(11):2186-92. PubMed ID: 8635020
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M, Kobayashi Y, Urawa N, Yamamoto M, Mifuji R, Araki J, Tanaka H, Horiike S, Itani T, Furjita N, Konishi M, Iwasa M, Kaito M, Adachi Y.
    Hepatogastroenterology; 2007 Mar 01; 54(74):518-21. PubMed ID: 17523311
    [Abstract] [Full Text] [Related]

  • 15. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
    Vitale FV, Romeo P, Vasta F, Panebianco V, Calì S, Rotondo S, Ferraù F, La Greca M.
    Anticancer Res; 2007 Mar 01; 27(6B):4077-81. PubMed ID: 18225574
    [Abstract] [Full Text] [Related]

  • 16. Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma.
    Urabe T, Kaneko S, Matsushita E, Unoura M, Kobayashi K.
    Oncology; 1998 Mar 01; 55(1):39-47. PubMed ID: 9428374
    [Abstract] [Full Text] [Related]

  • 17. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
    Pazdur R, Ajani JA, Patt YZ, Gomez J, Bready B, Levin B.
    Cancer; 1993 Feb 15; 71(4):1214-8. PubMed ID: 8435795
    [Abstract] [Full Text] [Related]

  • 18. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
    Tanaka K, Yabushita Y, Nakagawa K, Kumamoto T, Matsuo K, Taguri M, Endo I.
    Eur J Surg Oncol; 2013 Dec 15; 39(12):1364-70. PubMed ID: 24183169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-alpha.
    Kurokohchi K, Takaguchi K, Kita K, Masaki T, Kuriyama S.
    World J Gastroenterol; 2005 Sep 14; 11(34):5401-3. PubMed ID: 16149157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.